Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 22, 2017
Pharmacy Choice - Pharmaceutical News - NHI Announces Fourth Quarter 2016 Results - November 22, 2017

Pharmacy News Article

 2/17/17 - NHI Announces Fourth Quarter 2016 Results

MURFREESBORO, Tenn.(BUSINESS WIRE) National Health Investors, Inc. (NYSE:NHI) announced today its net income attributable to common stockholders, its Funds From Operations ("FFO"), its Normalized Funds From Operations and its Normalized Adjusted Funds From Operations (AFFO) for the three and twelve months ended December31, 2016.

2016 Highlights

  • Announced $447.7 million in acquisitions and loans
  • Issued $104.2 million of common equity on the Company's ATM
  • Normalized AFFO up 11.7% over fourth quarter 2015; up 7.1% for 2016
  • Maintained low leverage balance sheet at 4.4x net debt-to-annualized adjusted EBITDA
  • Portfolio lease coverage remains strong at 1.83x
  • Converted RIDEA joint venture with Bickford Senior Living to triple-net tenancy

Financial Results

  • Net income attributable to common stockholders per diluted common share for the three months ended December31, 2016, was $1.03, a decrease of 28.4% from the same period in the prior year. Net income attributable to common stockholders per diluted common share for the year ended December31, 2016, was $3.87, a decrease of 2.0% from the prior year.
  • Normalized FFO per diluted common share for the three months ended December31, 2016, was $1.27, an increase of 8.5% over the same period in the prior year. Normalized FFO per diluted common share for the year ended December31, 2016, was $4.87, an increase of 4.3% over the prior year.
  • Normalized AFFO per diluted common share for the three months ended December31, 2016 was $1.15, an increase of 11.7% over the same period in the prior year. Normalized AFFO per diluted common share for the year ended December31, 2016 was $4.39, an increase of 7.1% over the prior year.
  • FFO per diluted common share for the three months ended December31, 2016, was $1.43, a decrease of 20.6% from the same period in the prior year. FFO per diluted common share for the year ended December31, 2016, was $5.25, a decrease of 1.1% from the prior year.
  • FFO and net income attributable to common stockholders for the three months ended December31, 2016 include gains on sales of marketable securities of $6.2 million compared to gains on sales of marketable securities of $23.5 million for the same period in the prior year. FFO and net income attributable to common stockholders for the year ended December31, 2016 include $29.7 million of gains on sales of marketable securities and $14.7 million in non-cash write-offs of a lease intangible and straight-line rent receivable related to the transition of a lease on a portfolio of 15 skilled nursing facilities to The Ensign Group.

The Company defines Normalized FFO as FFO adjusted for certain items which may create some difficulty in comparing FFO for the current period to similar prior periods. We define Normalized AFFO as Normalized FFO excluding the effects of straight-line lease revenue, amortization of debt issuance costs and the non-cash amortization of the original issue discount of our unsecured convertible notes. These supplemental non-GAAP performance measures may not be comparable to similarly titled measures used by other REITs.

Net income attributable to common stockholders is a calculation of our net income, defined as the results of our operations in conformity with generally accepted accounting principles (GAAP) in the United States of America, less net income attributable to noncontrolling interests in our consolidated joint ventures, if any.

The reconciliation of net income attributable to common stockholders to our FFO, Normalized FFO, Normalized AFFO and Normalized FAD is included as a table to this press release and filed in the Company's Form 10-Q with the Securities and Exchange Commission.

2017 Guidance

The Company currently expects Normalized FFO for 2016 to be in the range of $5.06 to $5.12 per diluted common share and Normalized AFFO to be in the range of $4.61 to $4.65 per diluted common share. The Company's guidance range for the full year 2016, with underlying assumptions and timing of certain transactions, is set forth and reconciled below:

Full-Year 2017 Range
Low High
Net income per diluted share attributable to common stockholders $ 3.47 $ 3.50
Plus: Depreciation 1.59 1.62
Normalized FFO per diluted common share $ 5.06 $ 5.12
Less: Straight-line rental income (0.54 ) (0.56 )
Plus: Amortization of debt issuance costs 0.06 0.06
Plus: Amortization of original issue discount 0.03 0.03
Normalized AFFO per diluted common share $ 4.61 $ 4.65

The Company's guidance range reflects the existence of volatile economic conditions, but does not assume any material deterioration in tenant credit quality and/or performance of its portfolio. The Company does not include an estimate of investment volume in its guidance range, however, it includes future investments with existing and new tenants for which management estimates are reasonably likely at the present date. The guidance is based on a number of assumptions, many of which are outside the Company's control and all of which are subject to change. The Company's guidance range allows for the uncertainty inherent in the structure and timing of the financing required to fund previously announced investments and any pending new investments. The Company's guidance may change if actual results vary from these assumptions.

Investor Conference Call and Webcast

NHI will host a conference call on Friday, February17, 2017, at 12 p.m. ET, to discuss fourth quarter results. The number to call for this interactive teleconference is (800) 699-3715 with the confirmation number, 21843254. The live broadcast of NHI's fourth quarter conference call will be available online at www.nhireit.com. The online replay will follow shortly after the call and continue for approximately 90 days.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. Visit www.nhireit.com for more information.

Reconciliation of FFO, Normalized FFO, Normalized AFFO and Normalized FAD
(in thousands, except share and per share amounts)
Three Months Ended Year Ended
December 31, December 31,
2016 2015 2016 2015
Net income attributable to common stockholders $ 41,188 $ 54,397 $ 151,540 $ 148,862
Elimination of certain non-cash items in net income:
Depreciation 15,897 13,660 59,565 53,163
Depreciation related to noncontrolling interest (301 ) (927 ) (1,150 )
Net gain on sales of real estate (4,582 ) (1,126 )
Funds from operations 57,085 67,756 205,596 199,749
Gain on sale of marketable securities (6,175 ) (23,468 ) (29,673 ) (23,529 )
Gain on sale of equity-method investee (1,657 )
Write-off of deferred tax asset 1,192
Non-cash write-off of straight-line rent receivable 9,456
Write-off of lease intangible 6,400
Revenue recognized due to early lease termination (303 )
Recognition of unamortized mortgage note discount (288 ) (288 )
Recovery of previous write-down (491 )
Normalized FFO 50,622 44,288 190,723 175,729
Straight-line lease revenue, net (5,615 ) (6,131 ) (22,198 ) (24,623 )
Straight-line lease revenue, net, related to noncontrolling interest 5 (4 ) 40
Amortization of original issue discount 291 279 1,145 1,101
Amortization of debt issuance costs 611 589 2,368 2,311
Amortization of debt issuance costs related to noncontrolling interest (9 ) (27 ) (30 )
Normalized AFFO 45,909 39,021 172,007 154,528
Non-cash stock based compensation 251 204 1,732 2,134
Normalized FAD $ 46,160

$ 39,225 $ 173,739 $ 156,662

BASIC

Weighted average common shares outstanding 39,847,860 37,727,868 39,013,412 37,604,594
FFO per common share $ 1.43 $ 1.80 $ 5.27 $ 5.31
Normalized FFO per common share $ 1.27 $ 1.17 $ 4.89 $ 4.67
Normalized AFFO per common share $ 1.15 $ 1.03 $ 4.41 $ 4.11

DILUTED

Weighted average common shares outstanding 39,993,445 37,741,162 39,155,380 37,644,171
FFO per common share $ 1.43 $ 1.80 $ 5.25 $ 5.31
Normalized FFO per common share $ 1.27 $ 1.17 $ 4.87 $ 4.67
Normalized AFFO per common share $ 1.15 $ 1.03 $ 4.39 $ 4.10

See Notes to Reconciliation of FFO, Normalized FFO, Normalized AFFO and Normalized FAD.

Notes to Reconciliation of FFO, Normalized FFO, Normalized AFFO and Normalized FAD

These supplemental operating performance measures may not be comparable to similarly titled measures used by other REITs. Consequently, our Funds From Operations ("FFO"), Normalized FFO, Normalized Adjusted Funds From Operations ("AFFO") and Normalized Funds Available for Distribution ("FAD") may not provide a meaningful measure of our performance as compared to that of other REITs. Since other REITs may not use our definition of these operating performance measures, caution should be exercised when comparing our Company's FFO, Normalized FFO, Normalized AFFO and Normalized FAD to that of other REITs. These financial performance measures do not represent cash generated from operating activities in accordance with generally accepted accounting principles ("GAAP") (these measures do not include changes in operating assets and liabilities) and therefore should not be considered an alternative to net earnings as an indication of operating performance, or to net cash flow from operating activities as determined by GAAP as a measure of liquidity, and are not necessarily indicative of cash available to fund cash needs.

Funds From Operations - FFO

FFO, as defined by the National Association of Real Estate Investment Trusts ("NAREIT") and applied by us, is net income (computed in accordance with GAAP), excluding gains (or losses) from sales of real estate property, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures, if any. The Company's computation of FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or have a different interpretation of the current NAREIT definition from that of the Company; therefore, caution should be exercised when comparing our Company's FFO to that of other REITs. Diluted FFO assumes the exercise of stock options and other potentially dilutive securities. Normalized FFO excludes from FFO certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing FFO for the current period to similar prior periods, and may include, but are not limited to, impairment of non-real estate assets, gains and losses attributable to the acquisition and disposition of assets and liabilities, and recoveries of previous write-downs.

We believe that FFO and normalized FFO are important supplemental measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative, and should be supplemented with a measure such as FFO. The term FFO was designed by the REIT industry to address this issue.

Adjusted Funds From Operations - AFFO

In addition to the adjustments included in the calculation of normalized FFO, normalized AFFO excludes the impact of any straight-line lease revenue, amortization of the original issue discount on our convertible senior notes and amortization of debt issuance costs.

We believe that normalized AFFO is an important supplemental measure of operating performance for a REIT. GAAP requires a lessor to recognize contractual lease payments into income on a straight-line basis over the expected term of the lease. This straight-line adjustment has the effect of reporting lease income that is significantly more or less than the contractual cash flows received pursuant to the terms of the lease agreement. GAAP also requires the original issue discount of our convertible senior notes and debt issuance costs to be amortized as non-cash adjustments to earnings. Normalized AFFO is useful to our investors as it reflects the growth inherent in the contractual lease payments of our real estate portfolio.

Funds Available for Distribution - FAD

In addition to the adjustments included in the calculation of normalized AFFO, normalized FAD excludes the impact of non-cash stock based compensation.

We believe that normalized FAD is an important supplemental measure of operating performance for a REIT as a useful indicator of the ability to distribute dividends to shareholders. Additionally, normalized FAD improves the understanding of our operating results among investors and makes comparisons with: (i) expected results, (ii) results of previous periods and (iii) results among REITs, more meaningful. Because FAD may function as a liquidity measure, we do not present FAD on a per-share basis.

Condensed Statements of Income
(in thousands, except share and per share amounts)
Three Months Ended Twelve Months Ended
December 31, December 31,
2016 2015 2016 2015
Revenues:
Rental income $ 61,019 $ 54,823 $ 232,393 $ 214,447
Interest income from mortgage and other notes 3,669 2,898 13,805 10,206
Investment income and other 339 982 2,302 4,335
65,027 58,703 248,500 228,988
Expenses:
Depreciation 15,897 13,660 59,565 53,163
Interest, including amortization of debt discount and issuance costs 11,364 10,158 43,108 37,629
Legal 16 169 422 464
Franchise, excise and other taxes 183 327 1,009 985
General and administrative 2,554 2,469 9,773 10,519
Loan and realty losses (recoveries) 15,856


Copyright Business Wire 2017

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Nov 29: Influenza 2017-2018: An Update on Prevention and Treatment
Nov 30: School is Out! Life is in Session: The Importance of Professional Development in Pharmacy
Dec 01: Anticoagulants: The Rapidly Changing Landscape
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415